Tadalafil NEW
| Price | $32 | $50 | $73 |
| Package | 10mg | 25mg | 50mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-17 |
Product Details
| Product Name: Tadalafil | CAS No.: 171596-29-5 |
| Purity: 99.53% | Supply Ability: 10g |
| Release date: 2026/07/17 |
Product Introduction
Bioactivity
| Name | Tadalafil |
| Description | Tadalafil (IC-351) is a carboline-based compound with vasodilatory activity that selectively inhibits the cyclic guanosine monophosphate (cGMP)-specific type 5 phosphodiesterase (PDE-5), preventing cGMP degradation in the smooth muscle of the corpus cavernosa and corpus spongiosum of the penis, thereby causing prolonged muscle relaxation, vasodilation, and enhanced penile erection. |
| In vitro | Tadalafil (at doses of 2 or 10 mg/kg) significantly promotes neural function recovery and increases both cerebral vascular density and the percentage of BrdU-positive endothelial cells. In rats undergoing sham surgery, Tadalafil (at a dose of 2 mg/kg) almost completely restored penile tissue oxygenation and countered the increase induced by nerve transection, while substantially enhancing the muscle/fiber ratio in certain penile tissue sections. When administered to the rat brain, Tadalafil selectively elevated cGMP levels rather than cyclic adenosine monophosphate. Furthermore, Tadalafil reduced the number of apoptotic cells in rats and increased the phosphorylation of kinase Akt and extracellular signal-regulated kinases 1/2 (two survival-related kinases). |
| In vivo | When acting on human hepatocytes, Tadalafil (1 mM) notably increases the expression of CYP3A proteins. Tadalafil can bind to type 5 phosphodiesterase (PDE5) with a dissociation constant (KD) of 2.4 nM, and this binding is stimulated by cyclic guanosine monophosphate (cGMP). |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 3.90 mg/mL (10.02 mM), Sonication is recommended. |
| Keywords | Tadalafil | Phosphodiesterase (PDE) | phosphodiesterase | PDE5 | Inhibitor | inhibit | IC351 | IC 351 | Apoptosis |
| Inhibitors Related | Stavudine | Aceglutamide | Urea | Tamoxifen | Cysteamine hydrochloride | D(+)-Raffinose pentahydrate | Metronidazole | Citric Acid Triammonium | Formamide | Dimethyl phthalate | Alginic acid | Sildenafil citrate |
| Related Compound Libraries | Highly Selective Inhibitor Library | Failed Clinical Trials Compound Library | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1.00 |
VIP8Y
|
.GZ HONESTCHEM CO.,LTD
|
2026-07-19 | |
| $10.00 |
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-07-19 | |
| $32.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-07-17 | |
|
VIP2Y
|
Xi an Biohorlden Industry Trade Co Ltd
|
2026-07-17 | ||
| $2.00 |
VIP3Y
|
Jinan Million Pharmaceutical Co., Ltd
|
2026-07-17 | |
|
VIP2Y
|
Forest chemical technology
|
2026-07-17 | ||
| $10.00 |
VIP1Y
|
Shanghai Zheng Peptide Plastic Co., Ltd.
|
2026-07-17 | |
| $10.00 |
VIP1Y
|
Ningbo Qingteng Plastic Cost.,Ltd.
|
2026-07-17 | |
| $1.00 |
VIP7Y
|
Jinan Jianfeng Chemical Co., Ltd
|
2026-07-17 | |
| $1.00 |
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2026-07-16 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY